Showing 1 to 12 of 20 results
Non-Invasive Ultrasound Technique Improves Cancer Diagnosis and Treatment
Researchers at Georgia Tech and Emory University developed a novel ultrasound technique using FDA-approved microbubbles to label and track macrophages in real-time, offering a non-invasive method for improved cancer diagnosis, prognosis, and treatment with potential applications in drug delivery and...
Non-Invasive Ultrasound Technique Improves Cancer Diagnosis and Treatment
Researchers at Georgia Tech and Emory University developed a novel ultrasound technique using FDA-approved microbubbles to label and track macrophages in real-time, offering a non-invasive method for improved cancer diagnosis, prognosis, and treatment with potential applications in drug delivery and...
Progress
40% Bias Score
Gates Advocates for Alzheimer's Research Following Father's Death
Bill Gates details his experience with his father's battle against Alzheimer's, highlighting the recent FDA approval of a blood-based diagnostic test as a significant breakthrough in early detection and treatment, advocating for increased research funding to combat the disease affecting over seven m...
Gates Advocates for Alzheimer's Research Following Father's Death
Bill Gates details his experience with his father's battle against Alzheimer's, highlighting the recent FDA approval of a blood-based diagnostic test as a significant breakthrough in early detection and treatment, advocating for increased research funding to combat the disease affecting over seven m...
Progress
40% Bias Score
Painless Nanopatch Revolutionizes Disease Diagnosis with Real-Time Molecular Analysis
King's College London researchers created a nanopatch with nano-needles a thousand times thinner than a human hair that extracts molecular information from tissue without causing pain or damage, enabling real-time disease monitoring and repeated sampling, as published in Nature Nanotechnology.
Painless Nanopatch Revolutionizes Disease Diagnosis with Real-Time Molecular Analysis
King's College London researchers created a nanopatch with nano-needles a thousand times thinner than a human hair that extracts molecular information from tissue without causing pain or damage, enabling real-time disease monitoring and repeated sampling, as published in Nature Nanotechnology.
Progress
52% Bias Score
Proteomics to Launch Highly Accurate Endometriosis Blood Test
Proteomics International Laboratories will commercially launch PromarkerEndo, a highly accurate blood test for endometriosis, in Australia during the third quarter of 2024, using a 'traffic light' risk assessment system to improve early diagnosis and reduce the current seven-year average delay.
Proteomics to Launch Highly Accurate Endometriosis Blood Test
Proteomics International Laboratories will commercially launch PromarkerEndo, a highly accurate blood test for endometriosis, in Australia during the third quarter of 2024, using a 'traffic light' risk assessment system to improve early diagnosis and reduce the current seven-year average delay.
Progress
64% Bias Score
Proteomics Secures $4.5M to Launch Novel Diagnostic Blood Tests
Proteomics International Laboratories secured $4.5 million to launch three novel blood tests (PromarkerD, PromarkerEso, PromarkerEndo) across Australia and the US, aiming to address significant unmet needs in diabetic kidney disease, oesophageal cancer, and endometriosis diagnosis.
Proteomics Secures $4.5M to Launch Novel Diagnostic Blood Tests
Proteomics International Laboratories secured $4.5 million to launch three novel blood tests (PromarkerD, PromarkerEso, PromarkerEndo) across Australia and the US, aiming to address significant unmet needs in diabetic kidney disease, oesophageal cancer, and endometriosis diagnosis.
Progress
48% Bias Score
New Blood Test Shows Promise for Early Pancreatic Cancer Detection
Researchers in Zurich and Portland have developed a blood test that detects pancreatic cancer in early stages with 73% accuracy, offering hope against this deadly disease with a historically low survival rate due to late diagnosis.
New Blood Test Shows Promise for Early Pancreatic Cancer Detection
Researchers in Zurich and Portland have developed a blood test that detects pancreatic cancer in early stages with 73% accuracy, offering hope against this deadly disease with a historically low survival rate due to late diagnosis.
Progress
32% Bias Score
Nasal Mucus: A Window into Health and Disease
Nasal mucus color and composition indicate health status: clear mucus suggests irritation, white a viral infection, yellow-green many dead leukocytes, and black a serious issue; research explores its microbiome's role in disease resistance and vaccine efficacy, with applications in personalized medi...
Nasal Mucus: A Window into Health and Disease
Nasal mucus color and composition indicate health status: clear mucus suggests irritation, white a viral infection, yellow-green many dead leukocytes, and black a serious issue; research explores its microbiome's role in disease resistance and vaccine efficacy, with applications in personalized medi...
Progress
4% Bias Score
Samsung's AI-Powered Medical Tech Dominates Spanish Market
Samsung's Spanish HME division surpasses 2024 goals, installing over 1,000 ultrasound machines and expanding into digital radiology and cardiovascular diagnostics, leveraging AI for faster, more precise diagnoses and improved patient care.
Samsung's AI-Powered Medical Tech Dominates Spanish Market
Samsung's Spanish HME division surpasses 2024 goals, installing over 1,000 ultrasound machines and expanding into digital radiology and cardiovascular diagnostics, leveraging AI for faster, more precise diagnoses and improved patient care.
Progress
44% Bias Score
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
Progress
56% Bias Score
Chinese Patent Granted for Proteomics' Muscle Stress Test
OxiDx Limited, a 66 percent-owned subsidiary of ASX-listed Proteomics International Laboratories, secured a Chinese patent for its muscle stress test, a rapid, low-cost blood test detecting muscle damage caused by oxidative stress, impacting athletes, racehorses, and general health.
Chinese Patent Granted for Proteomics' Muscle Stress Test
OxiDx Limited, a 66 percent-owned subsidiary of ASX-listed Proteomics International Laboratories, secured a Chinese patent for its muscle stress test, a rapid, low-cost blood test detecting muscle damage caused by oxidative stress, impacting athletes, racehorses, and general health.
Progress
52% Bias Score
OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.
OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.
Progress
48% Bias Score
Nutromics Raises \$35 Million for Breakthrough Wearable Diagnostic Patch
Nutromics, an Australian medical technology company, has raised \$35 million to develop a wearable diagnostic patch using synthetic DNA-based sensors; this technology enables continuous, real-time monitoring of multiple clinically relevant targets for some of the deadliest diseases, with clinical tr...
Nutromics Raises \$35 Million for Breakthrough Wearable Diagnostic Patch
Nutromics, an Australian medical technology company, has raised \$35 million to develop a wearable diagnostic patch using synthetic DNA-based sensors; this technology enables continuous, real-time monitoring of multiple clinically relevant targets for some of the deadliest diseases, with clinical tr...
Progress
48% Bias Score
Showing 1 to 12 of 20 results